54 related articles for article (PubMed ID: 31891487)
1. Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.
Membreno R; Keinänen OM; Cook BE; Tully KM; Fung KC; Lewis JS; Zeglis BM
Mol Pharm; 2019 May; 16(5):2259-2263. PubMed ID: 30912951
[TBL] [Abstract][Full Text] [Related]
2. N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion protein.
Yoo B; Cheal SM; Torchon G; Dilhas A; Yang G; Pu J; Punzalan B; Larson SM; Ouerfelli O
Bioconjug Chem; 2013 Dec; 24(12):2088-103. PubMed ID: 24147780
[TBL] [Abstract][Full Text] [Related]
3. Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM; Chung SK; Vaughn BA; Cheung NV; Larson SM
J Nucl Med; 2022 Sep; 63(9):1302-1315. PubMed ID: 36215514
[TBL] [Abstract][Full Text] [Related]
4. Correction to An
Cheal SM; Patel M; Yang G; Veach DR; Xu H; Guo HF; Zanzonico PB; Axworthy DB; Cheung NV; Ouerfelli O; Larson SM
Bioconjug Chem; 2021 Feb; 32(2):394. PubMed ID: 33486949
[No Abstract] [Full Text] [Related]
5. Pretargeted Radioimmunotherapy of Ovarian Cancer with
Li X; Lan X; Cai W
J Nucl Med; 2023 Sep; 64(9):1446-1448. PubMed ID: 37591542
[No Abstract] [Full Text] [Related]
6. Efficacy of HER2-Targeted Intraperitoneal
Chung SK; Vargas DB; Chandler CS; Katugampola S; Veach DR; McDevitt MR; Seo SH; Vaughn BA; Rinne SS; Punzalan B; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Yang G; Ouerfelli O; Nash GM; Cercek A; Fung EK; Howell RW; Larson SM; Cheal SM; Cheung NV
J Nucl Med; 2023 Sep; 64(9):1439-1445. PubMed ID: 37348919
[TBL] [Abstract][Full Text] [Related]
7. Clearing and Masking Agents in Pretargeting Strategies.
Staudt M; Herth MM
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111254
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
Chandler CS; Bell MM; Chung SK; Veach DR; Fung EK; Punzalan B; Burnes Vargas D; Patel M; Xu H; Guo HF; Santich BH; Zanzonico PB; Monette S; Nash GM; Cercek A; Jungbluth A; Pandit-Taskar N; Cheung NKV; Larson SM; Cheal SM
Mol Cancer Ther; 2022 Jan; 21(1):125-137. PubMed ID: 34667111
[TBL] [Abstract][Full Text] [Related]
9. IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.
Handula M; Chen KT; Seimbille Y
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361793
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthetic Strategies, and Therapeutic Applications of Heterofunctional Glycodendrimers.
Mousavifar L; Roy R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33921945
[TBL] [Abstract][Full Text] [Related]
11. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.
Dacek MM; Veach DR; Cheal SM; Carter LM; McDevitt MR; Punzalan B; Burnes Vargas D; Kubik TZ; Monette S; Santich BH; Yang G; Ouerfelli O; Kesner AL; Cheung NV; Scheinberg DA; Larson SM; Krebs S
Bioconjug Chem; 2021 Apr; 32(4):649-654. PubMed ID: 33819023
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting.
Myrhammar A; Vorobyeva A; Westerlund K; Yoneoka S; Orlova A; Tsukahara T; Tolmachev V; Karlström AE; Altai M
Sci Rep; 2020 Nov; 10(1):20777. PubMed ID: 33247180
[TBL] [Abstract][Full Text] [Related]
13. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
14. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.
Santich BH; Cheal SM; Ahmed M; McDevitt MR; Ouerfelli O; Yang G; Veach DR; Fung EK; Patel M; Burnes Vargas D; Malik AA; Guo HF; Zanzonico PB; Monette S; Michel AO; Rudin CM; Larson SM; Cheung NK
Clin Cancer Res; 2021 Jan; 27(2):532-541. PubMed ID: 32958698
[TBL] [Abstract][Full Text] [Related]
15. An
Cheal SM; Patel M; Yang G; Veach D; Xu H; Guo HF; Zanzonico PB; Axworthy DB; Cheung NV; Ouerfelli O; Larson SM
Bioconjug Chem; 2020 Mar; 31(3):501-506. PubMed ID: 31891487
[TBL] [Abstract][Full Text] [Related]
16. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
Cheal SM; Xu H; Guo HF; Lee SG; Punzalan B; Chalasani S; Fung EK; Jungbluth A; Zanzonico PB; Carrasquillo JA; O'Donoghue J; Smith-Jones PM; Wittrup KD; Cheung NV; Larson SM
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):925-937. PubMed ID: 26596724
[TBL] [Abstract][Full Text] [Related]
17. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
